Want to see AU:TLX full AI Analyst Report?
Telix Pharmaceuticals (TLX) Income Statement
652 Followers
Telix Pharmaceuticals Income Statement
Last quarter (Q2 2026), Telix Pharmaceuticals's total revenue was AU$467.85M, an increase of 147.59% from the same quarter last year. In Q2, Telix Pharmaceuticals's net income was AU$37.57M. See Telix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| AU$ 816.72M | AU$ 783.21M | AU$ 502.55M | AU$ 160.10M | AU$ 7.60M | |
| AU$ 433.78M | AU$ 509.68M | AU$ 314.39M | AU$ 29.34M | AU$ -29.77M | |
| AU$ 415.73M | AU$ 427.55M | AU$ 263.27M | AU$ 102.52M | AU$ 51.48M | |
| Depreciation and Amortization | AU$ 22.13M | AU$ 8.20M | AU$ 6.92M | AU$ 5.38M | AU$ 5.17M |
| AU$ 40.18M | AU$ 90.10M | AU$ 23.15M | AU$ -92.84M | AU$ -70.07M | |
| AU$ 18.05M | AU$ 82.13M | AU$ 52.63M | AU$ -73.18M | AU$ -81.25M | |
| AU$ -23.40M | AU$ -26.07M | AU$ -48.43M | AU$ -25.44M | AU$ -17.79M | |
| AU$ -5.35M | AU$ 56.06M | AU$ 3.09M | AU$ -98.62M | AU$ -99.04M | |
| AU$ -7.24M | AU$ 49.92M | AU$ 5.21M | AU$ -104.08M | AU$ -80.51M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.02 | AU$ 0.15 | AU$ 0.02 | AU$ -0.34 | AU$ -0.29 |
| Diluted EPS | AU$ -0.02 | AU$ 0.14 | AU$ 0.02 | AU$ -0.34 | AU$ -0.29 |
| Weighted Average Shares Outstanding | 337.88M | 331.23M | 319.18M | 310.64M | 282.21M |
| Weighted Average Shares Outstanding (Diluted) | 337.88M | 345.19M | 323.71M | 310.64M | 282.21M |
Currency in AUD
